[PHARMA] YoY Quarter Result on 30-Jun-2013 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-Aug-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Jun-2013 [#2]
Profit Trend
QoQ- -76.32%
YoY- -62.67%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 531,796 512,845 525,072 437,633 456,737 396,435 350,335 7.19%
PBT 21,487 25,056 24,622 9,605 27,618 19,380 20,327 0.92%
Tax -5,846 -8,414 -8,665 -3,434 -11,541 -5,335 -5,809 0.10%
NP 15,641 16,642 15,957 6,171 16,077 14,045 14,518 1.24%
-
NP to SH 14,995 16,217 15,975 5,865 15,713 13,920 14,747 0.27%
-
Tax Rate 27.21% 33.58% 35.19% 35.75% 41.79% 27.53% 28.58% -
Total Cost 516,155 496,203 509,115 431,462 440,660 382,390 335,817 7.41%
-
Net Worth 524,177 528,477 502,293 480,568 481,394 451,517 417,065 3.87%
Dividend
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Div 12,949 18,134 10,356 8,810 8,827 - 50,261 -20.21%
Div Payout % 86.36% 111.82% 64.83% 150.22% 56.18% - 340.83% -
Equity
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Net Worth 524,177 528,477 502,293 480,568 481,394 451,517 417,065 3.87%
NOSH 258,981 259,057 258,914 258,370 117,700 106,994 106,939 15.86%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin 2.94% 3.25% 3.04% 1.41% 3.52% 3.54% 4.14% -
ROE 2.86% 3.07% 3.18% 1.22% 3.26% 3.08% 3.54% -
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
RPS 205.34 197.97 202.80 169.38 388.05 370.52 327.60 -7.48%
EPS 5.79 6.26 6.17 2.27 13.35 13.01 13.79 -13.45%
DPS 5.00 7.00 4.00 3.41 7.50 0.00 47.00 -31.14%
NAPS 2.024 2.04 1.94 1.86 4.09 4.22 3.90 -10.34%
Adjusted Per Share Value based on latest NOSH - 258,370
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
RPS 36.90 35.58 36.43 30.37 31.69 27.51 24.31 7.19%
EPS 1.04 1.13 1.11 0.41 1.09 0.97 1.02 0.32%
DPS 0.90 1.26 0.72 0.61 0.61 0.00 3.49 -20.20%
NAPS 0.3637 0.3667 0.3485 0.3334 0.334 0.3133 0.2894 3.87%
Price Multiplier on Financial Quarter End Date
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Date 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 -
Price 5.50 7.13 4.61 4.49 10.18 5.90 4.98 -
P/RPS 2.68 3.60 2.27 2.65 2.62 1.59 1.52 9.90%
P/EPS 94.99 113.90 74.72 197.80 76.25 45.35 36.11 17.47%
EY 1.05 0.88 1.34 0.51 1.31 2.21 2.77 -14.91%
DY 0.91 0.98 0.87 0.76 0.74 0.00 9.44 -32.26%
P/NAPS 2.72 3.50 2.38 2.41 2.49 1.40 1.28 13.37%
Price Multiplier on Announcement Date
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Date 19/08/16 17/08/15 21/08/14 16/08/13 08/08/12 10/08/11 11/08/10 -
Price 5.62 5.65 4.62 4.66 8.83 5.90 4.95 -
P/RPS 2.74 2.85 2.28 2.75 2.28 1.59 1.51 10.43%
P/EPS 97.06 90.26 74.88 205.29 66.14 45.35 35.90 18.01%
EY 1.03 1.11 1.34 0.49 1.51 2.21 2.79 -15.28%
DY 0.89 1.24 0.87 0.73 0.85 0.00 9.49 -32.57%
P/NAPS 2.78 2.77 2.38 2.51 2.16 1.40 1.27 13.93%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment